Which Antidepressants Cause Night Sweats?

Most commonly prescribed antidepressants can cause night sweats, and the problem is more widespread than many people realize. Excessive sweating affects roughly one in five patients taking antidepressants, with both SSRIs and SNRIs approximately tripling the risk compared to placebo. A few specific drugs stand out as exceptions, and understanding which ones are less likely to drench your sheets can make a real difference if you and your prescriber are weighing options.

How Common the Problem Actually Is

Night sweats from antidepressants are not a rare side effect buried in fine print. Across the broader category of antidepressant-induced excessive sweating, the estimated prevalence sits around 22% of patients.¹ That figure encompasses daytime sweating, nighttime sweating, or both. The problem often goes underreported because patients may not connect waking up soaked to a medication they take for mood, or they may feel embarrassed bringing it up.

A primary care study looking specifically at night sweats found that after accounting for age and sex, SSRI users were about three times more likely to report night sweats than non-users.² That’s a meaningful bump in odds, and it held up even when the researchers controlled for other medications and health conditions. For context, the only other drug classes that showed a comparable association in that study were certain blood pressure medications and thyroid supplements.

SSRIs and SNRIs Carry Similar Risk

If you’re hoping one of these two major antidepressant classes is clearly safer than the other when it comes to sweating, the data are disappointing. A meta-analysis pooling results from randomized trials found that SNRIs roughly tripled the risk of excessive sweating compared to placebo, and SSRIs did essentially the same thing. The difference between the two classes was not statistically meaningful.³ In practical terms, switching from an SSRI like sertraline to an SNRI like venlafaxine, or vice versa, is unlikely to solve the sweating problem by itself.

This makes sense when you consider the mechanism. Sweating is regulated by the sympathetic nervous system through noradrenergic signaling, and serotonin has both inhibitory and excitatory influences on that central noradrenergic transmission.⁴ Both SSRIs and SNRIs increase serotonin activity, so both end up poking at the thermoregulatory system. SNRIs add norepinephrine reuptake inhibition on top of that, which you might expect would make them worse, but the meta-analysis suggests the serotonin piece is doing most of the heavy lifting when it comes to sweating.

Among specific drugs within these classes, the meta-analysis did not find major standouts. The pattern was broadly consistent: if a drug meaningfully raises serotonin levels, it tends to increase sweating risk. The real differences show up not between individual SSRIs or SNRIs, but between these serotonin-active classes and a handful of antidepressants that work differently.

The Antidepressants That Don’t Seem to Cause It

Three antidepressants stood out in the meta-analysis as not being significantly associated with excessive sweating compared to placebo: bupropion, fluvoxamine, and vortioxetine.³ Each is worth understanding separately, because they’re quite different drugs with different trade-offs.

Bupropion works primarily on dopamine and norepinephrine rather than serotonin, which likely explains why it doesn’t trigger the same thermoregulatory disruption. It’s often prescribed for people who’ve had sexual side effects or weight gain on SSRIs, and its low sweating risk adds another practical reason a prescriber might consider it. The trade-off is that bupropion is less effective for anxiety than SSRIs, and it carries a dose-dependent seizure risk, so it’s not the right fit for everyone.

Fluvoxamine is technically an SSRI, which makes its appearance on the low-risk list surprising. Its confidence interval in the meta-analysis was wide, meaning the data were sparse, and the result could be a statistical artifact of small sample sizes rather than a genuine biological difference. Prescribers don’t typically reach for fluvoxamine to dodge night sweats based on this evidence alone.

Vortioxetine is a newer antidepressant with a more complex mechanism that includes serotonin modulation alongside reuptake inhibition. Its sweating risk was not significantly elevated, though again the confidence interval left room for uncertainty. If you’re looking for an antidepressant with a lower sweating profile and your prescriber is open to newer agents, vortioxetine is at least a conversation starter.

Why Serotonin Makes You Sweat

Your body’s temperature control relies on the hypothalamus, which acts as a thermostat. When the hypothalamus decides you’re too warm, it signals sweat glands through the sympathetic nervous system. That signaling chain is primarily noradrenergic, meaning it runs on norepinephrine. Serotonin sits upstream of this process, influencing the central noradrenergic neurons that ultimately control the sweat command. The relationship is not straightforward: serotonin can both excite and inhibit those pathways, depending on which receptors are activated.⁴

When an SSRI floods the system with more serotonin than usual, the balance of those excitatory and inhibitory effects shifts. In many patients, the net result is that the hypothalamic thermostat becomes more trigger-happy, lowering the threshold at which the body decides to start sweating. During sleep, your core body temperature naturally dips and fluctuates, and a recalibrated thermostat can interpret those normal fluctuations as overheating, kicking off a full sweat response when none is really needed. That’s why you can wake up drenched in a perfectly cool room.

This also explains why the sweating often starts within the first few weeks of treatment or after a dose increase: the serotonin system is adjusting to a new baseline. Some patients find the sweating eases over months as the body adapts, but for others it persists for as long as they take the medication.

Who Is More Likely to Be Affected

The 22% average masks real variation from person to person. Some of that variation is genetic. Your liver processes most antidepressants using a set of enzymes, and one called CYP2D6 handles a large share of them. People inherit different versions of the gene for this enzyme. A pilot study found that among patients experiencing adverse effects from antidepressants metabolized by CYP2D6, about 29% turned out to be poor metabolizers, meaning their bodies broke down the drug much more slowly than average. That rate was roughly four times higher than what you’d expect in the general population.⁵ Slower metabolism means higher drug levels in the blood from the same dose, which in turn means more serotonergic activity and a greater chance of side effects like sweating.

Pharmacogenomic testing, which identifies your CYP2D6 status through a cheek swab or blood test, is increasingly available. If you’ve had unusually strong side effects from standard doses of antidepressants in the past, this test can tell your prescriber whether your genetics are amplifying the drug’s effects.

Sex also plays a role, though in a direction that might not match expectations. In a controlled study of sertraline-treated patients who were given a medication to combat the sweating, female patients reported lower subjective sweating than males overall.⁶ Whether that reflects a genuine biological difference in sweat gland response or a difference in reporting is hard to tease apart, but prescribers should be aware that the experience can differ between men and women.

The Menopause Paradox

Here’s where the picture gets genuinely strange. SSRIs and SNRIs are among the most commonly recommended non-hormonal treatments for hot flashes in menopausal and postmenopausal women. A review of the literature found that paroxetine, citalopram, escitalopram, and venlafaxine all reduced the frequency and severity of menopausal hot flashes.⁷ Paroxetine even has FDA approval specifically for this purpose. Yet these same drugs independently increase sweating risk in the broader population.

How can a drug simultaneously reduce hot flashes and cause night sweats? The answer lies in different mechanisms. Menopausal hot flashes are driven by hormonal changes that narrow the thermoneutral zone in the hypothalamus, making it overreact to tiny temperature shifts. SSRIs appear to widen that thermoneutral zone back out, calming the hot-flash trigger. Antidepressant-induced sweating, meanwhile, likely operates through a different serotonergic pathway that lowers the general sweating threshold. The two effects can coexist in the same patient, which means a menopausal woman might experience fewer classic hot flashes but develop a new pattern of nighttime sweating that feels similar but has a different cause.

For women in menopause who are prescribed an SSRI or SNRI partly for hot flashes, tracking whether sweating patterns change after starting the medication is especially important. A reduction in daytime flushing combined with new nighttime drenching episodes is a recognizable pattern, and it’s worth raising with a doctor rather than assuming the medication isn’t working.

What You Can Do About It

If you’re dealing with antidepressant-related night sweats, you have several options beyond simply suffering through it or stopping your medication.

Dose adjustment: Since the sweating effect is dose-dependent for many antidepressants, lowering the dose (with your prescriber’s guidance) can sometimes bring it under control while still maintaining the antidepressant effect. This is a balancing act and shouldn’t be done on your own.
Switching medications: If your current antidepressant is working well for your mood but the sweating is unbearable, switching to bupropion or vortioxetine may preserve the mental health benefit with less sweating risk. The meta-analysis data provide a reasonable basis for that conversation.³
Add-on medication: Oxybutynin, an anticholinergic drug more commonly used for overactive bladder, has been shown in a placebo-controlled trial to reduce excessive sweating in patients taking sertraline for major depression. The side effects of oxybutynin itself were uncommon in that study.⁶
Waiting it out: For some patients, the sweating is worst during the first weeks on a new antidepressant or after a dose increase and gradually improves. If you can tolerate it short-term, it may resolve without intervention.

Some patients find behavioral strategies helpful as well: sleeping in moisture-wicking fabrics, keeping the bedroom cool, using a fan, and avoiding alcohol or spicy food before bed. These won’t fix the underlying pharmacological cause, but they can make the experience less miserable while you and your doctor figure out a longer-term plan.

Ruling Out Other Causes

Before blaming your antidepressant entirely, it’s worth recognizing that night sweats have a long list of potential contributors. Infections, hormonal conditions, sleep apnea, and other medications can all cause them independently. The primary care study that linked SSRIs to night sweats also found significant associations with thyroid supplements and certain blood pressure drugs.² If you take multiple medications, untangling which one (or which combination) is responsible requires careful attention to timing.

The clearest signal that your antidepressant is the culprit is temporal: the sweating started within days to weeks of beginning the medication or increasing the dose, and it wasn’t present before. If the sweating preceded the antidepressant, or if it persists long after you stop taking it, other explanations deserve investigation. Your doctor may want to check thyroid function, screen for infections, or evaluate hormonal status before assuming the antidepressant is the sole cause.

Why This Side Effect Gets Overlooked

Antidepressant-induced sweating occupies an odd space in clinical practice. It’s common enough that roughly one in five patients experiences it, yet it rarely makes the top of the list when prescribers discuss potential side effects. Sexual dysfunction, weight gain, and emotional blunting tend to dominate those conversations. Part of the issue is that sweating doesn’t show up on standard depression scales or symptom checklists, so unless a patient volunteers the information, it can go unnoticed in follow-up appointments.

There’s also a dismissal problem. Night sweats feel mundane compared to more dramatic adverse events, and patients sometimes hear “try different sheets” or “keep your room cooler” from clinicians who may not realize there are pharmacological options. The evidence for treatments like oxybutynin exists and is reasonably strong, but awareness among general practitioners lags behind what the specialty literature has shown. If your prescriber isn’t familiar with add-on treatments for antidepressant sweating, asking specifically about anticholinergic options or a medication switch gives them something concrete to look into.

The broader consequence of untreated night sweats isn’t just discomfort. Repeated sleep disruption erodes the very mood stability that the antidepressant is supposed to provide. Waking up multiple times a night to change clothes or flip a pillow undermines sleep quality, and poor sleep is both a symptom and a driver of depression. In that sense, ignoring antidepressant-induced sweating can quietly undermine the treatment itself, making it all the more important to address rather than accept as an unavoidable cost of feeling better.